1. Rosenberg N, Jolicoeur P. Retroviral pathogenesis. 1997 [cited]. http://www.ncbi.nlm.nih.gov/books/NBK19378/
2. Rosenberg N, Jolicoeur P. Retroviral pathogenesis. In: Coffin J, Hughes S, Varmus H, editors. Retroviruses. Plainview, NY: Cold Spring Harbor Laboratory Press; 1997. p. 475–583.
3. Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA. 1985;253(2):221–5.
4. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868–71.
5. Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, et al. Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986;1(8481):575–80.